[1/5] #Glioblastoma comprises 49.1% of all primary malignant brain tumors and approximately 12,000 cases are diagnosed each year in the US. A recent study In @JAMAOnc investigated whether the addition of an...
[3/5] DCVax-L was found to be promising in extending survival for patients with newly diagnosed glioblastoma who are also receiving standard treatment for their disease. #HealthcareNews#medicine#MedEd
[5/5] We also have a visual abstract for you, summarizing a study demonstrating that #Carboplatin holds potential as an adjunct therapy for recurrent high-grade #glioma treatment.
• • •
Missing some Tweet in this thread? You can try to
force a refresh